Jean-Yves Blay

Direktor/Vorstandsmitglied bei INNATE PHARMA

Vermögen: 118 $ am 30.04.2024

61 Jahre

Health Technology

Consumer Services

Commercial Services

Aktive Positionen von Jean-Yves Blay

Unternehmen	Position	Beginn	Ende
INNATE PHARMA	Direktor/Vorstandsmitglied	13.12.2017	-
INNATE PHARMA	Independent Dir/Board Member	13.12.2017	-
TRANSGENE	Direktor/Vorstandsmitglied	25.05.2022	-
TRANSGENE	Independent Dir/Board Member	25.05.2022	-
Centre Léon Bérard Lyon et Rhône-Alpes	Vorstandsvorsitzender	01.01.2014	-

Unternehmen	Position	Beginn	Ende
UNICANCER UNICANCER Hospital/Nursing ManagementHealth Services UNICANCER is a French hospital network that is dedicated to fighting against cancer. The private company is based in Paris, France. It is the only national hospital federation that is solely focused on oncology. The network comprises of 18 French cancer centers (CLCC) and a private non-profit health establishment. The CLCCs take care of almost 530,000 patients annually. UNICANCER is also a leading academic promoter of clinical trials in oncology in Europe, with 106 active clinical trials promoted and nearly 7,600 patients included.	Präsident	01.01.2019	01.01.2022
European Organisation for Research & Treatment of Cancer	Präsident	01.01.2009	01.01.2012
Académie Nationale de Médecine FCP	Corporate Officer/Principal	01.01.2016	-

Université Claude Bernard Lyon 1

Doctorate Degree

International

Frankreich	7
Belgien	2

Operativ

Director/Board Member	2
Independent Dir/Board Member	2
President	2

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
INNATE PHARMA	Health Technology
TRANSGENE	Health Technology

Private Unternehmen	4
Centre Léon Bérard Lyon et Rhône-Alpes
Académie Nationale de Médecine FCP	Commercial Services
European Organisation for Research & Treatment of Cancer
UNICANCER UNICANCER Hospital/Nursing ManagementHealth Services UNICANCER is a French hospital network that is dedicated to fighting against cancer. The private company is based in Paris, France. It is the only national hospital federation that is solely focused on oncology. The network comprises of 18 French cancer centers (CLCC) and a private non-profit health establishment. The CLCCs take care of almost 530,000 patients annually. UNICANCER is also a leading academic promoter of clinical trials in oncology in Europe, with 106 active clinical trials promoted and nearly 7,600 patients included.	Health Services